Loading...

Merck & Co., Inc.

6MK.DEXETRA
HealthcareDrug Manufacturers - General
70.00
-0.90(-1.27%)

Merck & Co., Inc. 6MK.DE Peers

See (6MK.DE) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
6MK.DE€70.00-1.27%175.8B11.67€6.00+3.78%
LLY.DE€709.30+1.81%672.2B66.17€10.72+0.64%
JNJ.DE€135.70-0.98%326.5B17.29€7.85+3.02%
4AB.DE€166.80+0.24%294.6B81.37€2.05+3.15%
ZEG.DE€128.75-0.35%199.6B29.67€4.34+2.12%
AMG.DE€255.60-1.06%137.4B26.71€9.57+3.32%
PFE.DE€21.37+0.23%121.5B17.66€1.21+6.58%
PFE.F€21.26-0.28%120.8B17.57€1.21+6.59%
GIS.DE€96.13-0.82%119.6B23.00€4.18+2.74%
SNW.DE€86.57-1.13%105.5B17.35€4.99+4.52%
Showing 1 to 10 of 15 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

6MK.DE vs LLY.DE Comparison

6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, LLY.DE has a market cap of 672.2B. Regarding current trading prices, 6MK.DE is priced at €70.00, while LLY.DE trades at €709.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6MK.DE currently has a P/E ratio of 11.67, whereas LLY.DE's P/E ratio is 66.17. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, 6MK.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.

Stock Price Comparison

Loading...

Frequently Asked Questions